Cadent Therapeutics
Signal active
Organization
Contact Information
Overview
Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. The company leverages its precision neuroscience approach combining target specificity, patient selection, drug design and optimization, and novel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders.
It was founded in 2010 and headquartered in Cambridge, Massachusetts.
About
Industries
Biotechnology, Health Care, Wellness, Medical Device, Therapeutics
Founded
2010
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Cadent Therapeutics headquartered in United States, North America, operates in the Biotechnology, Health Care, Wellness, Medical Device, Therapeutics sector. The company focuses on Biotechnology and has secured $6.7B in funding across 100 round(s). With a team of 11-50 employees, Cadent Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Cadent Therapeutics, raised $5.4M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
5
Investors
2
Lead Investors
0
Total Funding Amount
$66.7M
Details
5
Cadent Therapeutics has raised a total of $66.7M in funding over 5 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2020 | Early Stage Venture | 15.0M | ||
| 2010 | Seed | 250.0K | ||
| 2013 | Early Stage Venture | 6.0M | ||
| 2012 | Early Stage Venture | 5.4M |
Investors
Cadent Therapeutics is funded by 16 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Cadent Therapeutics | - | FUNDING ROUND - Cadent Therapeutics | 15.0M |
| Novartis Institutes for Biomedical Research | - | FUNDING ROUND - Novartis Institutes for Biomedical Research | 15.0M |
| Cadent Therapeutics | - | FUNDING ROUND - Cadent Therapeutics | 250.0K |
| Slater Technology Fund | - | FUNDING ROUND - Slater Technology Fund | 250.0K |
Recent Activity
There is no recent news or activity for this profile.